Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging

Journal of Nanobiotechnology

Volumn 9, Issue , 2011, Pages

  Jasmin, ^a,b   Torres, Ana Luiza M ^a   Nunes, Henrique M P ^a   Passipieri, Juliana A ^a   Jelicks, Linda A ^b   Gasparetto, Emerson L ^a   Spray, David C ^b   Campos de Carvalho, Antonio C ^a,b   Mendez Otero, Rosalia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTES; BIOLOGICAL PROPERTIES; BONE MARROW; CELL TRACKING; CELL TYPES; CHONDROCYTES; FERUMOXIDES; HOST TISSUES; HUMAN USE; IMMUNOCYTOCHEMISTRY; IN-VITRO; IN-VIVO; LONG LASTING; MESENCHYMAL CELLS; MITOMYCIN C; NON-INVASIVE; OSTEOCYTES; POLY-L-LYSINE; PRE-TREATMENT; STEM CELL THERAPY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; THERAPEUTIC POTENTIALS;

AMINO ACIDS; BIOMATERIALS; CELL PROLIFERATION; DEXTRAN; DISEASE CONTROL; FLOWCHARTING; GLUCOSE; IRON OXIDES; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; RESONANCE; STEM CELLS; SUPERPARAMAGNETISM; VISUALIZATION;

CELL CULTURE;

KI 67 ANTIGEN; MITOMYCIN C; NANOPARTICLE; POLYLYSINE; PROTAMINE; SUPERPARAMAGNETIC IRON OXIDE; CARBOXYDEXTRAN COATED MAGNETIC IRON OXIDE PARTICLES; CARBOXYDEXTRAN-COATED MAGNETIC IRON OXIDE PARTICLES; IRON; MAGNETITE NANOPARTICLE; MITOMYCIN; OXIDE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LABELING; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCYTE; RAT; ANIMAL; BONE MARROW; C57BL MOUSE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; MESENCHYMAL STEM CELL; METHODOLOGY; STAINING; WISTAR RAT; ERRATUM; ERROR;

RATTUS;

ADIPOCYTES; ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MITOMYCIN; OSTEOCYTES; OXIDES; POLYLYSINE; PROTAMINES; RATS; RATS, WISTAR; STAINING AND LABELING;

EID: 79651473781     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-9-4     Document Type: Article

References (61)

1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98:10344-10349. 10.1073/pnas.181177898, 56963, 11504914.
2. Wu J, Sun Z, Sun HS, Weisel RD, Keating A, Li ZH, Feng ZP, Li RK. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 2008, 16:993-1005. 10.3727/000000007783472435, 18351015.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147. 10.1126/science.284.5411.143, 10102814.
4. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98. 10.1161/hc0102.101442, 11772882.
5. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584. 10.1016/j.biocel.2003.11.001, 15010324.
6. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843. 10.1182/blood.V99.10.3838, 11986244.
7. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729. 10.1182/blood-2002-07-2104, 12506037.
8. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621. 10.1182/blood-2003-11-3909, 15001472.
9. Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004, 13:263-271. 10.1089/154732804323099190, 15186722.
10. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 2006, 24:462-471. 10.1634/stemcells.2004-0331, 16109759.
11. Guzman R, Uchida N, Bliss TM, He D, Christopherson KK, Stellwagen D, Capela A, Greve J, Malenka RC, Moseley ME, et al. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci USA 2007, 104:10211-10216. 10.1073/pnas.0608519104, 1891235, 17553967.
12. Sykova E, Jendelova P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 2007, 14:1336-1342. 10.1038/sj.cdd.4402140, 17396130.
13. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002, 99:16267-16272. 10.1073/pnas.242435499, 138600, 12444255.
14. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys J 1999, 76:103-109. 10.1016/S0006-3495(99)77182-1, 1302504, 9876127.
15. Jendelova P, Herynek V, Urdzikova L, Glogarova K, Kroupova J, Andersson B, Bryja V, Burian M, Hajek M, Sykova E. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004, 76:232-243. 10.1002/jnr.20041, 15048921.
16. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 2004, 101:10901-10906. 10.1073/pnas.0403918101, 503717, 15256592.
17. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O'Brien FJ, van Osch G, Bernsen M. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 2008, 369:1076-1081. 10.1016/j.bbrc.2008.02.159, 18336785.
18. Modo M, Cash D, Mellodew K, Williams SC, Fraser SE, Meade TJ, Price J, Hodges H. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage 2002, 17:803-811. 10.1006/nimg.2002.1194, 12377155.
19. Yang J, Liu J, Niu G, Chan KC, Wang R, Liu Y, Wu EX. In vivo MRI of endogenous stem/progenitor cell migration from subventricular zone in normal and injured developing brains. Neuroimage 2009, 48:319-328. 10.1016/j.neuroimage.2009.06.075, 19591946.
20. Shapiro EM, Gonzalez-Perez O, Manuel Garcia-Verdugo J, Alvarez-Buylla A, Koretsky AP. Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain. Neuroimage 2006, 32:1150-1157. 10.1016/j.neuroimage.2006.04.219, 16814567.
21. Vreys R, Vande Velde G, Krylychkina O, Vellema M, Verhoye M, Timmermans JP, Baekelandt V, Van der Linden A. MRI visualization of endogenous neural progenitor cell migration along the RMS in the adult mouse brain: validation of various MPIO labeling strategies. Neuroimage 2010, 49:2094-2103. 10.1016/j.neuroimage.2009.10.034, 19850132.
22. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000, 18:410-414. 10.1038/74464, 10748521.
23. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD, Zinn K, Forder J, Josephson L, Weissleder R, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods 2001, 256:89-105. 10.1016/S0022-1759(01)00433-1, 11516758.
24. Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003, 49:1006-1013. 10.1002/mrm.10465, 12768577.
25. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003, 228:480-487. 10.1148/radiol.2281020638, 12819345.
26. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol 1990, 155:943-950.
27. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989, 152:167-173.
28. Molday RS, MacKenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982, 52:353-367. 10.1016/0022-1759(82)90007-2, 7130710.
29. Babic M, Horak D, Trchova M, Jendelova P, Glogarova K, Lesny P, Herynek V, Hajek M, Sykova E. Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 2008, 19:740-750. 10.1021/bc700410z, 18288791.
30. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003, 76:1123-1130. 10.1097/01.TP.0000089237.39220.83, 14557764.
31. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004, 104:1217-1223. 10.1182/blood-2004-02-0655, 15100158.
32. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, Varma NR, Frank JA, Arbab AS. Optimization and validation of FePro cell labeling method. PLoS One 2009, 4:e5873. 10.1371/journal.pone.0005873, 2690694, 19517015.
33. van Buul GM, Farrell E, Kops N, van Tiel ST, Bos PK, Weinans H, Krestin GP, van Osch GJ, Bernsen MR. Ferumoxides-protamine sulfate is more effective than ferucarbotran for cell labeling: implications for clinically applicable cell tracking using MRI. Contrast Media Mol Imaging 2009, 4:230-236. 10.1002/cmmi.289, 19839030.
34. Reynolds F, Weissleder R, Josephson L. Protamine as an efficient membrane-translocating peptide. Bioconjug Chem 2005, 16:1240-1245. 10.1021/bc0501451, 16173804.
35. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975, 69:685-689.
36. Gervin AS. Complications of heparin therapy. Surg Gynecol Obstet 1975, 140:789-796.
37. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 1997, 4:961-968. 10.1038/sj.gt.3300484, 9349433.
38. Reddy AM, Kwak BK, Shim HJ, Ahn C, Cho SH, Kim BJ, Jeong SY, Hwang SJ, Yuk SH. Functional characterization of mesenchymal stem cells labeled with a novel PVP-coated superparamagnetic iron oxide. Contrast Media Mol Imaging 2009, 4:118-126. 10.1002/cmmi.271, 19308999.
39. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004, 17:513-517. 10.1002/nbm.925, 15526348.
40. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005, 18:553-559. 10.1002/nbm.991, 16229060.
41. Bourrinet P, Bengele HH, Bonnemain B, Dencausse A, Idee JM, Jacobs PM, Lewis JM. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 2006, 41:313-324. 10.1097/01.rli.0000197669.80475.dd, 16481915.
42. Walczak P, Zhang J, Gilad AA, Kedziorek DA, Ruiz-Cabello J, Young RG, Pittenger MF, van Zijl PC, Huang J, Bulte JW. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574. 10.1161/STROKEAHA.107.502047, 2857730, 18323495.
43. Hu SL, Zhang JQ, Hu X, Hu R, Luo HS, Li F, Xia YZ, Li JT, Lin JK, Zhu G, Feng H. In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem 2009, 108:529-535. 10.1002/jcb.22283, 19623584.
44. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW. Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn Reson Med 2007, 58:261-269. 10.1002/mrm.21280, 17654572.
45. Yocum GT, Wilson LB, Ashari P, Jordan EK, Frank JA, Arbab AS. Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats. Radiology 2005, 235:547-552. 10.1148/radiol.2352040383, 15858093.
46. Ramaswamy S, Greco JB, Uluer MC, Zhang Z, Fishbein KW, Spencer RG. Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage. Tissue Eng Part A 2009, 15:3899-3910. 10.1089/ten.tea.2008.0677, 2792067, 19788362.
47. Henning TD, Sutton EJ, Kim A, Golovko D, Horvai A, Ackerman L, Sennino B, McDonald D, Lotz J, Daldrup-Link HE. The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol Imaging 2009, 4:165-173. 10.1002/cmmi.276, 2933782, 19670250.
48. Mailander V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 2008, 10:138-146. 10.1007/s11307-007-0130-3, 18297365.
49. Hsiao JK, Tai MF, Chu HH, Chen ST, Li H, Lai DM, Hsieh ST, Wang JL, Liu HM. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 2007, 58:717-724. 10.1002/mrm.21377, 17899592.
50. Qiu B, Yang X. Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis. Nat Clin Pract Cardiovasc Med 2008, 5:396-404. 10.1038/ncpcardio1217, 18477983.
51. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005, 54:769-774. 10.1002/mrm.20701, 16161115.
52. Tai JH, Foster P, Rosales A, Feng B, Hasilo C, Martinez V, Ramadan S, Snir J, Melling CW, Dhanvantari S, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 2006, 55:2931-2938. 10.2337/db06-0393, 17065328.
53. Qiu B, Xie D, Walczak P, Li X, Ruiz-Cabello J, Minoshima S, Bulte JW, Yang X. Magnetosonoporation: instant magnetic labeling of stem cells. Magn Reson Med 2010, 63:1437-1441. 10.1002/mrm.22348, 20512844.
54. Klein CL, Wagner M, Kirkpatrick CJ, Van Kooten TG. A new quantitative test method for cell proliferation based on detection of the Ki-67 protein. J Mater Sci Mater Med 2000, 11:125-132. 10.1023/A:1008953319485, 15348057.
55. Wang P, Henning SM, Heber D. Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One 2010, 5:e10202. 10.1371/journal.pone.0010202, 2855713, 20419137.
56. Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 1997, 69:581-593. 10.1046/j.1471-4159.1997.69020581.x, 9231715.
57. Nieman BJ, Shyu JY, Rodriguez JJ, Garcia AD, Joyner AL, Turnbull DH. In vivo MRI of neural cell migration dynamics in the mouse brain. Neuroimage 2010, 50:456-464. 10.1016/j.neuroimage.2009.12.107, 2899477, 20053381.
58. Kim HS, Oh SY, Joo HJ, Son KR, Song IC, Moon WK. The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed 2010, 23:514-522. 10.1002/nbm.1487, 20175151.
59. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, Williams SC. Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 2004, 21:311-317. 10.1016/j.neuroimage.2003.08.030, 14741669.
60. Brekke C, Morgan SC, Lowe AS, Meade TJ, Price J, Williams SC, Modo M. The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed 2007, 20:77-89. 10.1002/nbm.1077, 16952123.
61. Greisberg JK, Wolf JM, Wyman J, Zou L, Terek RM. Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res 2001, 19:797-801. 10.1016/S0736-0266(01)00025-0, 11562123.